Approval Details

The Nomination and Remuneration Committee of the Board of Directors approved the allotment via Circular Resolution on 16th November, 2026.

Allotment Details

  • Total equity shares allotted: 5,23,989 (Five Lakhs Twenty-Three Thousand Nine Hundred and Eighty-Nine)
  • Face value: ₹2 per share
  • Recipients: Eligible employees of the Company

Share Characteristics

The newly allotted shares will rank pari-passu with existing shares of the Company in all respects.

Capital Structure Impact

Consequent to the allotment:

  • Pre-allotment equity shares: 19,52,78,626 shares
  • Post-allotment equity shares: 19,58,02,615 shares
  • Increase of 5,23,989 shares

ESOP Scheme Details

Exercise Price Breakdown

The options were exercised at five different price points:

  • 744 shares at ₹16 per share
  • 9,634 shares at ₹24 per share
  • 3,25,881 shares at ₹40 per share
  • 95,550 shares at ₹50 per share
  • 92,180 shares at ₹96 per share
Financial Proceeds

Total money realized by exercise of options: ₹2,69,05,140 (excluding tax)

Scheme Compliance

The scheme is in terms of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

Significant Terms
  • The equity shares arising on exercise of options rank pari-passu with all other equity shares
  • No lock-in restrictions except those imposed by applicable laws
Earnings Impact

The diluted earnings per share for the year ended 31 March 2026 is ₹1.75 per share.

Additional Information

  • Options vested: 5,23,989 (Vesting Schedule: Not Applicable)
  • Exercise period: Not Applicable
  • Options lapsed: Not Applicable
  • Variation of terms: Not Applicable
  • Subsequent changes/cancellation: Not Applicable